• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Medical Device Market
Medical Device News
Medical Device Stocks
  • Medical Device Market
  • Medical Device News
  • Medical Device Stocks
medical device investing

LED Medical Diagnostics Posts Q3 Financial Results

Bryan Mc Govern
Nov. 28, 2017 09:07AM PST
Medical Device Investing

LED Medical Diagnostics announced its financial result for the third quarter of 2017.

LED Medical Diagnostics (TSXV:LMD; OTCQB:LEDIF) announced its financial result for the third quarter of 2017.
As quoted in the press release:

Business Highlights and Events Subsequent to the Quarter

  • American Dental Partners selected LED Medical Diagnostics subsidiary Apteryx as their provider for cloud dental imaging software technologies. American Dental Partners will transition their entire network–nearly 300 US-based dental and specialty practices–to Apteryx’s XVWeb cloud imaging technology within the next 12 months.
  • Dental Care Alliance selected LED Medical Diagnostics as preferred imaging technology providers for dental imaging devices and software technologies. Dental Care Alliance is one of the United States’ largest and oldest dental support organizations, with 265 affiliated practices across all of the dental specialties in 13 states.
  • On October 30, 2017 (the ”closing date”), the Company issued 250 senior secured debentures with a principle amount of CDN $2,500,000 (US$1,938,690), maturing 24 months from the closing date. Each unit consists of a debenture in principal in the amount of CDN $10,000 and 21,250 common shares of the company and is attached with a 12% coupon. The Company issued 888,000 broker warrants (the ”Broker’s Warrants”) to arm’s length brokers. Each Broker’s Warrant is non-transferrable and exercisable at an exercise price of CDN $0.10 at any time up to and including the date which is 24 months from the closing date. Transaction costs associated with this issuance were CDN $232,031.65 (US$179,935) and have been netted against the debenture proceeds received. Certain insiders of LED, including a director and officer, acquired units in the offering.

Dr. David Gane, CEO of LED stated, ”I am pleased to report that Q3 was near breakeven EBITDA from operations for the three months ended September 30, 2017 at US ($58,673). Revenues in Q3 declined over the prior quarter due to the lower sales seasonality typically seen in the summer months as well as a dip in Apteryx software revenues as we transition from sales of our perpetual license software to our cloud based XV Web software as a service (SaaS) subscription model.”

Click here to read the full press release.

Source: www.accesswire.com

led medical diagnostics broker warrants led medical medical device investing united states
The Conversation (0)

Go Deeper

AI Powered
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

Doctor looking into a microscope

5 Small Medical Device Companies

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Medical Device Investing Stocks

Cardiex Limited

Cardiex Limited (CDX:AU)
CDX:AU

Cleo Diagnostics

Cleo Diagnostics (COV:AU)
COV:AU

Ocumetics Technology

Ocumetics Technology (OTC:CC)
OTC:CC

Avricore Health

Avricore Health (AVCR:CC)
AVCR:CC
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES